23andMe CEO addresses FDA setback

23andMe CEO Anne Wojcicki talks about the challenges her company faces in working with the FDA to get approval to market its DNA kits.

Most Popular

  • untitled
This video series features interviews with C-Level executives, high-level business leaders and policy makers covering strategy and current affairs from the perspective of the corner office.